InxMed
- Website
- en.inxmed.com
- Total Funding
- $65.0M
- Last Round
- $15.0M Series BMay 2022
- Rounds
- 2
About
InxMed is a Biotech company. It has raised $65.0M in total across 2 rounds, most recently a $15.0M Series B round in May 2022. Investors include China Growth Capital, SDIC Fund Management and CD Capital.
Funding History
May 2022
Sign up to see all 2 rounds
Series B — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Calico researches human aging using advanced technologies and model systems, applying that knowle...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/inxmed"><img src="https://indexed.vc/api/badge/company/inxmed" alt="InxMed on Indexed.vc" width="260" height="76" /></a>